JenaValve, a Munich, Germany-based medical device company focuses on developing new aortic valves that can be implanted via the femoral vein or an incision between two ribs, has raised €19m in Series B financing round.
The investment was led by Gimv, with participation from Atlas Venture, Edmond de Rothschild Investment Partners, Neomed Management, VI Partners and Sunstone Capital.
In 2006-2007, the company already raised €13.5m in a first financing round.
This capital round should enable JenaValve to further develop its products and get them ready to market.
FinSMEs
31/03/2010